Spikevax bivalent Original/Omicron BA.1
Spikevax bivalent Original/Omicron BA.1 is indicated for active immunisation to prevent COVID 19 caused by SARS-CoV-2 in individuals 12 years of age and older who have previously received at least a primary vaccination course against COVID 19.
COVID‑19 Vaccine Moderna
Emergency Use Authorization (EUA) has been amended for the COVID-19 mRNA Vaccine (now known as Spikevax) in the Philippines to expand the therapeutic indication to 6 years of age and older.
Tools
Contact Moderna
8am-5pm PHT – Mon - Fri
APACmedinfo@modernatx.com